Data / Form D filings / Tango Therapeutics, Inc.
Tango Therapeutics, Inc.: Form D filings
Tango Therapeutics, Inc., a pharmaceuticals company in Boston, MA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on October 28, 2025, reports $15 million sold of a $15 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 BROOKLINE AVENUE, SUITE 901, Boston, MA, 02215
- Phone
- (857) 320-4900
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1819133
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | New notice | $14,999,995 | $14,999,995 | 1 | Oct 24, 2025 | sec.gov | |
| Aug 24, 2023 | New notice | $80,016,604 | $80,016,604 | 17 | Aug 11, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Ann Ketchum | Director | |
| Barbara Weber | Executive Officer, Director | |
| Malte Ann Peters | Director | |
| Kanishka Ann Pothula | Director | |
| Lesley Ann Calhoun | Director | |
| Mace Ann Rothenberg | Director | |
| Alexis Borisy | Director | |
| Adam Crystal | Executive Officer | |
| Daniella Beckman | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Oct 27, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Tango Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.